Cargando…
AREG mediates the epithelial-mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF-κB signalling pathway
Amphiregulin (AREG) is a member of the epidermal growth factor (EGF) family and is expressed in a plethora of cancers. The biological roles of AREG in the regulation of the epithelial-mesenchymal transition (EMT) in pancreatic cancer remain unclear. To investigate the expression of epidermal growth...
Autores principales: | Wang, Li, Wang, Lili, Zhang, Hui, Lu, Junliang, Zhang, Zhiwen, Wu, Huanwen, Liang, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107775/ https://www.ncbi.nlm.nih.gov/pubmed/32323797 http://dx.doi.org/10.3892/or.2020.7523 |
Ejemplares similares
-
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022) -
Loss of KIBRA function activates EGFR signaling by inducing AREG
por: Mussell, Ashley L., et al.
Publicado: (2018) -
miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
por: Tung, S-L, et al.
Publicado: (2017) -
Interleukin 17A promotes gallbladder cancer invasiveness via ERK/NF-κB signal pathway mediated epithelial-to-mesenchymal transition
por: Chen, Kunlun, et al.
Publicado: (2020) -
PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway
por: Tang, Dong, et al.
Publicado: (2017)